Rhonda Hellums

Insider Reports History

Location
Leawood, KS
Signature
/s/ Rhonda Hellums
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Rhonda Hellums:

Company Role Class Num Shares Value Price $ Report Date Ownership
Silence Therapeutics plc Chief Financial Officer, Director Employee Share Option (Right to Buy) 375,000 02 Jan 2026 Direct

Insider Reports Filed by Rhonda Hellums

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SLN Silence Therapeutics plc 02 Jan 2026 1 $0 4 Chief Financial Officer, Director 06 Jan 2026, 16:15
SLN Silence Therapeutics plc 02 Jan 2025 1 $0 4 Chief Financial Officer 06 Jan 2025, 16:15
SLN Silence Therapeutics plc 02 Jan 2025 0 $0 3 Chief Financial Officer 02 Jan 2025, 16:32